Empowering confident healthcare decisions through trusted laboratory service & diagnostic excellence. BioReference® Health LLC, an OPKO Health, Inc.
Company (NASDAQ: OPK), empowers confident healthcare decisions by prioritizing service, creating innovative solutions, and offering scientific expertise in oncology, urology, and women’s health. Headquartered in Elmwood Park, New Jersey, BioReference operates 10 laboratory facilities around the country, is in-network with the largest health plans in the United States and processes more than 12 mil
lion tests, annually. BioReference provides credible and tailored solutions for a variety of customers and patients, including medical practices small and large, hospitals and health systems, correctional institutions, government agencies, educational systems, and sport leagues. In addition to an extensive test menu with 99 percent of tests performed in-house, BioReference’s differentiated offerings include large-scale health screening programs, on-demand mobile phlebotomy, and transformative business solutions that optimize laboratory management. For more information visit https://www.bioreference.com/
10/31/2024
We are thrilled that Ellen Beausang, Chief Commercial Officer at BioReference/GenPath, will be one of the featured speakers at the pre-conference workshop at Pathology Visions '24 on November 3, 2024. Ellen will speak about how we successfully integrated artificial intelligence into our remote pathology offering, Stormpath, and how this helps our clients report professional interpretations of esoteric testing more quickly and accurately.
Be the first to know and let us send you an email when BioReference Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
BioReference has a reputation for doing things differently, and our vision is more expansive than just solving today’s problems. Our foresight and ingenuity have moved us from a concept to a billion-dollar laboratory practice, setting us on a course to advance modern medicine. While unparalleled diagnostics remain at our core, our ultimate goal is to help physicians provide better service and to empower patients with the knowledge to better care for themselves.
Our full-service offering goes beyond the lab; our people and expertise are impacting every area of medicine. GenPath Oncology maintains a strategic advantage in relation to other diagnostic laboratories that revolves around three key areas: clinical expertise, scientific innovation and cost effectiveness. GenPath Women’s Health was founded because we understand women’s health needs and know that with the right screening, testing and research we can save lives. GeneDx is at the forefront of genetic screening and analysis because nothing can be more precise than a diagnosis based on an individual’s DNA. Laboratorio Buena Salud exists because we believe you shouldn’t have to “press 2” to reach someone who speaks your own language.
Our laboratories are adapting to an evolving industry, and constantly investing in the resources, people and technology that will benefit our business, our clients and our patients in the long term. With an unwavering focus on the needs of tomorrow, we’re blazing a trail for the future of our industry – one that is built by doctors, for doctors and patients.
